FIGURE 1.
Overall survival. Overall survival of all patients with stage IV non‐small cell lung cancer (NSCLC) in our cohort who received immunotherapy in the first‐ or second‐line of treatment alone or in combination with chemotherapy.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.